1. Kristich, C. J., Rice, L. B. & Arias, C. A. Enterococcal infection – treatment and antibiotic resistance. In: Enterococci: from commensals to leading causes of drug-resistant infection. Eds Gilmore, M. S., Clewell, D. B., Ike, Y., Shankar, N. Boston: Massachusetts Eye and Ear Infirmary, pp. 123–184, https://www.ncbi.nlm.nih.gov/books/NBK190424/pdf/Bookshelf_NBK190424.pdf (Date of access: 02/02/2017) (2014).
2. Alvarez, R., Lopez Cortes, L. E. & Molina, J. et al. Optimizing the clinical use of vancomycin. Ant Ag Chemo. 60, 2601–2609 (2016).
3. Mackay, J. P. et al. Glycopeptide antibiotic activity and the possible role of dimerization: a model for biological signalling. J Am Chem Soc. 116, 4581–4590 (1994a).
4. Jia, Z., O’Mara, M. L., Zuegg, J., Cooper, M. A. & Mark, A. E. Vancomycin: ligand recognition, dimerization and super-complex formation. FEBS J. 280, 1294–1307 (2013).
5. Nieto, M. & Perkins, H. R. The specificity of combination between ristocetins and peptides related to bacterial cell wall mucopeptide precursors. Biochem J. 124, 845–852 (1971).